At Keystone Symposia Conference to be held between 22-27 March 2015
Cadila Healthcare announced that the Zydus Group will be making an oral presentation on Saroglitazar, a novel compound under development for treatment in Non-alcoholic Steatohepatitis (NASH), at the Keystone Symposium on Liver Metabolism and Non-Alcoholic Fatty Liver Disease (NAFLD) to be held on 22 to 27 March 2015 in British Columbia, Canada.Powered by Capital Market - Live News